Get started
Cronos Group Inc. Common ShareCronos Group Inc. Common ShareCronos Group Inc. Common Share

Cronos Group Inc. Common Share

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

CRON trade ideas

What's Next After CRON Quarterly Release? Even with a report of reduced enthusiasm for legalized pot in Canada, Cronos Group (CRON) reported a positive earnings surprise of $0.36 (US) versus estimates for a $0.03 (US) loss. Revenues continue to expand however, issues with distribution, packaging and licensing resulted in slower quarter-over quarter growth. As a result, Cronos Group's stock dropped 12.5% in yesterday's trading session. FlashPoint Trading Academy entered a long position at $14.17 on this weakness as the stock has reached initial support at its previous breakout point. Further support can be found at its 250 EMA. Our initial target is set at $17.30 and stop-on-close below $13.15. This represents a 1:3 Risk:Reward. Please click the Like button and Follow our highly successful trade ideas. Thank you for supporting us!
NASDAQ:CRONLong
by AlgoTrend
$CRON They highs have worn off in Cannabis. Like all others within the sector CRON has hit a brick wall as investors have rung the register and moved onto more stable sectors. Commentators have referenced the Cannabis stocks as a bubble sector and looking at the charts it is difficult to argue. Cronos by no fault of its own, has reached a crazy valuation while still in the development stages. This earnings report may give a spike in revenue but also a spike in costs which may trigger more selling. On the positive side it could be suggested that the stock is already washed out after months of continual selling, the declining volume profile is a good gauge. Company Description Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC).
NASDAQ:CRONShort
by RedHotStocks
CRON Weekly AnalysisCRON formed a high two bull flag which triggered last week. Instead of resuming the bull trend, prices are continuing lower. There is a bear gap which is still open at $17.80. There has been some decent selling pressure over the past 8 or so weeks with very little buying pressure since the parabolic wedge reversal. The bears will likely get a larger second leg down before the bulls resume buying. If the bears are able to fill all of the bull gaps from the January rally, it will increase the likelihood of a transition into a trading range and test of the $7 tight trading range.
NASDAQ:CRON
by tradersmentality
CRON Setup Looking at the larger time frames, you can see that we have retested the 50 week MA multiple times during this bull run. What I would like to see for an ideal setup is a back test of the support line at around $13, which if timed right would coincide with the 50 week MA. MACD is still trending up, and the RSI is approaching a significant support zone. The current bounce in price action has yet to indicate any kind of real strength, and it looks as if we are just in a bear flag. With this in mind, I believe that we will drop into the Buy Zone highlighted, where I will be looking to scale in some Long positions. Thanks for viewing, good luck trading!
NASDAQ:CRONLong
by kickflip360
CRON at FIB618Sometimes you just need to zoom out more, to get the broader picture. With CRON trading at 11 times forward revenue at the CURRENT price, it is still extremely expensive. Disappointing results, nothing much to show for all its promise. It seems to me that the only thing it has going for it right now, is Altria's cash. Looking at the weekly charts, it would seem that the dreamers are keeping this baby from imploding, while she certainly is on her way to the bottom trend line. We have to remember that RSI and other indicators are calculated based on recent price history. A low RSI certainly doesn't mean that CRON is oversold, and it is definitely no guarantee that the bottom has been reached. I will be considering CRON below $13. Even then, it will still be VERY expensive. Don't get me wrong, I do believe that CRON is a contender in the future, but the current levels leave very little short term upside, in my honest opinion. I'll wait for some really good news from CRON, or for a better valuation. Thanks for looking.
NASDAQ:CRON
by Barkworth
Long CRON at logarithmic trend-line support.The first time I was introduced to CRON it was at $23/share and my first thought was it was a sell. Now that the early buyers have taken their profit and more states are looking at legalizing marijuana, it is ready for another run to new highs. Using a logarithmic scale and Fibonacci retracement, we can see that the 61.8 lines up very nicely with an ascending trendline support. May 1st looks to be a point where multiple important signals will coincide. Price should reach the 61.8 retracement and trend-line support, daily RSI comes back above 30, stochastic comes back above 20, and the MACD will likely cross all in the same week. My plan is to take a small long position at ~$14/share with 1:1 leverage and likely no stop loss as this will be a long term hold. As price confirms the upward direction, I will scale into the trade adding a trailing stop equal to slightly under the ascending support line.
NASDAQ:CRONLong
by louisleeiv
3